Notable safety advantages : Lower discontinuation rates due to adverse events (4-7%) compared to reported rates with semaglutide 2.4 mg in STEP trials (approximately 6-7%) No signal for diabetic retinopathy worsening (a concern identified with semaglutide in SUSTAIN-6) No evidence of increased psychiatric adverse events (depression, suicidality) Research Applications Tirzepatide serves as a groundbreaking research tool across multiple biomedical domains: Dual incretin biology : Studying the synergistic effects of simultaneous GIP and GLP-1 receptor activation on glucose homeostasis, appetite, and metabolism Adipose tissue biology : Investigating GIPR-mediated effects on adipocyte differentiation, lipid buffering, and adipokine secretion mechanisms absent from GLP-1 agonist research Central appetite neuroscience : Mapping distinct GIP vs
RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis
Cell therapies using mesenchymal stem cells (MSCs, also known as medicinal signaling cells) have shown promise for these nonreplacement strategies (Chan et al., 2021)
In addition to its direct antioxidant functions, glutathione (GSH) contributes to the regeneration of other antioxidants, including vitamins C and E, and is involved in critical processes such as iron homeostasis and mitochondrial integrity
Maier L, Pruteanu M, Kuhn M, et al
While growth hormone is ineffective in diabetic animals their growth is enhanced by IGF-1
